Anna Penalba Selected Research

Anna Penalba Research Topics

Disease

39	Stroke (Strokes) 05/2024 - 07/2005
26	Ischemic Stroke 05/2024 - 07/2005
9	Brain Ischemia (Cerebral Ischemia) 11/2023 - 11/2009
7	Atrial Fibrillation 12/2022 - 12/2016
7	Cerebral Hemorrhage 01/2021 - 06/2008
6	Hemorrhagic Stroke 01/2021 - 01/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022 - 07/2005
4	Ischemia 11/2023 - 01/2013
4	Hypertension (High Blood Pressure) 01/2017 - 02/2014
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 03/2016 - 08/2010
3	Inflammation (Inflammations) 01/2020 - 01/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2012 - 09/2011
3	Transient Ischemic Attack 01/2012 - 05/2008
2	Cognitive Dysfunction 12/2022 - 01/2020
2	Infarction (Infarctions) 07/2022 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2016
2	Diabetes Mellitus 01/2018 - 01/2013
2	Infections 11/2017 - 01/2013
2	Brain Infarction 12/2016 - 12/2014
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2014 - 07/2008
2	Brain Injuries (Brain Injury) 06/2009 - 07/2005
1	Epilepsy (Aura) 04/2024
1	Hypothermia 11/2023
1	Cardiomyopathies (Cardiomyopathy) 04/2022
1	Neuroinflammatory Diseases 01/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Sepsis (Septicemia) 11/2017
1	Heart Diseases (Heart Disease) 12/2016
1	Vascular Diseases (Vascular Disease) 12/2016
1	Dementia (Dementias) 12/2016
1	Thrombophilia 01/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2015
1	Cerebral Small Vessel Diseases 12/2014
1	Leukemia 05/2014

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2009
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
5	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 12/2016
5	Matrix Metalloproteinases (MMPs)IBA 03/2012 - 07/2005
4	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 12/2016
4	ChemokinesIBA 01/2020 - 01/2009
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 12/2014 - 09/2011
3	CytokinesIBA 05/2014 - 11/2009
3	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2014 - 05/2006
3	Metalloproteases (Metalloproteinases)IBA 08/2010 - 07/2005
2	salicylhydroxamic acid (SHAM)IBA 07/2022 - 01/2018
2	ProteomeIBA 01/2018 - 01/2018
2	EndostatinsIBA 01/2017 - 05/2011
2	Amyloid (Amyloid Fibrils)IBA 03/2016 - 01/2012
2	ApolipoproteinsIBA 03/2016 - 01/2016
2	Fibrinogen (Factor I)FDA Link 01/2016 - 05/2006
2	Plasminogen Activator Inhibitor 1IBA 05/2014 - 05/2006
2	erucylphosphocholineIBA 01/2013 - 12/2010
2	5'-palmitoyl cytarabine (PLAC)IBA 02/2012 - 09/2011
2	C-Reactive ProteinIBA 05/2008 - 05/2006
1	Atrial Natriuretic Factor (ANF)IBA 05/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2024
1	ProcalcitoninIBA 05/2024
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 11/2023
1	Vehicle Emissions (Emissions, Vehicle)IBA 11/2023
1	purineIBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	Fatty Acid-Binding ProteinsIBA 11/2023
1	Troponin T (Troponin T1)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	ImmunosorbentsIBA 03/2021
1	EnzymesIBA 03/2021
1	angiogeninIBA 01/2021
1	Aquaporins (Water Channels)IBA 01/2020
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2019
1	Galectin 3 (LGALS3)IBA 12/2016
1	Troponin IIBA 09/2016
1	TroponinIBA 09/2016
1	Protein Isoforms (Isoforms)IBA 03/2016
1	Apolipoproteins E (ApoE)IBA 03/2016
1	Apolipoprotein E4IBA 03/2016
1	LipidsIBA 03/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	AntibodiesIBA 01/2016
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2016
1	Glial Fibrillary Acidic ProteinIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	CholesterolIBA 12/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2014
1	Interleukin-12 Subunit p40IBA 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014
1	beta-DefensinsIBA 05/2014
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2014
1	4-(fluoromethyl)phenyl phosphate (FMPP)IBA 02/2014
1	GelsolinIBA 12/2013
1	Cystatin AIBA 12/2013
1	Conditioned Culture MediaIBA 01/2013
1	InterferonsIBA 01/2013

Therapy/Procedure

6	Therapeutics 01/2021 - 07/2008
3	Secondary Prevention 01/2020 - 01/2009
2	Lasers (Laser) 01/2018 - 06/2009
2	Thrombolytic Therapy 11/2009 - 07/2005
1	Induced Hypothermia 11/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013